Eiger BioPharmaceuticals, Inc.
EIGRDelisted Apr 25, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001305253
Eiger BioPharmaceuticals, Inc. was delisted on Apr 25, 2024; its insiders filed their last Form 4 on Nov 2, 2023; 43 institutions reported holding it in 13F filings for Q4 2023, worth $4.16M in total; no superinvestor held it.
13F holders, Q1 2024
Institutional positions in Eiger BioPharmaceuticals, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
EIGR is no longer listed, and 13F filings after Q4 2023 list far fewer holders. See Q4 2023
- Institutional holders
- 24
- −18 vs. Q4 2023
- Shares held
- 666.8K
- +69.3K (+11.6%) vs. Q4 2023Converted for a 1-for-31 split
- Total value
- $3.19M
- −$966.1K (−23.3%) vs. Q4 2023
- New holders
- 3
- 9 more added
- Sold out
- 21
- 9 more reduced
1 institution that held it in Q4 2023 haven't filed for Q1 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting EIGR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 1 | $423.0K |
| Q1 2025 | 1 | $423.0K |
| Q4 2024 | 1 | $765.0K |
| Q3 2024 | 1 | $1.24M |
| Q2 2024 | 2 | $1.85M |
| Q1 2024 | 24 | $3.19M |
| Q4 2023 | 43 | $4.16M |
| Q3 2023 | 51 | $6.08M |
| Q2 2023 | 67 | $14.6M |
| Q1 2023 | 71 | $22.2M |
| Q4 2022 | 81 | $29.6M |
| Q3 2022 | 92 | $225.3M |
| Q2 2022 | 91 | $187.8M |
| Q1 2022 | 95 | $252.0M |
| Q4 2021 | 86 | $124.1M |
| Q3 2021 | 92 | $151.0M |
| Q2 2021 | 90 | $196.3M |
| Q1 2021 | 94 | $207.5M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Eiger BioPharmaceuticals, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ameriprise Financial Inc | 250,178 | $1.25M | 0.00% | +8,064+3.3% | AddedConverted for a 1-for-31 split |
| Propel Bio Management, LLC | 146,381 | $731.9K | 0.43% | +4,722+3.3% | AddedConverted for a 1-for-31 split |
| Simplify Asset Management Inc. | 90,000 | $450.0K | 0.04% | +90,000 | New |
| Accretive Wealth Partners, LLC | 63,150 | $169.9K | 0.08% | +63,150 | New |
| 683 Capital Management, LLC | 29,660 | $148.4K | 0.02% | −38,082−56.2% | ReducedConverted for a 1-for-31 split |
| Vanguard Group Inc | 28,201 | $141.1K | 0.00% | −30,533−52.0% | ReducedConverted for a 1-for-31 split |
| BlackRock Inc. | 19,109 | $95.6K | 0.00% | +279+1.5% | AddedConverted for a 1-for-31 split |
| Geode Capital Management, LLC | 12,652 | $63.3K | 0.00% | +403+3.3% | AddedConverted for a 1-for-31 split |
| Renaissance Technologies LLC | 11,102 | $56.0K | 0.00% | 00.0% | UnchangedConverted for a 1-for-31 split |
| RBF Capital, LLC | 10,971 | $54.9K | 0.00% | 00.0% | UnchangedConverted for a 1-for-31 split |
| Tower Research Capital LLC (TRC) | 1,948 | $9.75K | 0.00% | +1,358+230.4% | AddedConverted for a 1-for-31 split |
| Bank of America Corp | 1,174 | $5.88K | 0.00% | −378−24.4% | ReducedConverted for a 1-for-31 split |
| Acadian Asset Management LLC | 1,064 | $5.00K | 0.00% | −4,552−81.1% | ReducedConverted for a 1-for-31 split |
| Royal Bank of Canada | 362 | $2.00K | 0.00% | +318+723.9% | AddedConverted for a 1-for-31 split |
| Morgan Stanley | 366 | $1.83K | 0.00% | −80−17.9% | ReducedConverted for a 1-for-31 split |
| Advisor Group Holdings, Inc. | 331 | $1.66K | 0.00% | +81+32.4% | AddedConverted for a 1-for-31 split |
| BNP Paribas Arbitrage, SA | 94 | $470 | 0.00% | 00.0% | UnchangedConverted for a 1-for-31 split |
| National Bank of Canada | 41 | $93 | 0.00% | −0−0.7% | ReducedConverted for a 1-for-31 split |
| Federation des caisses Desjardins du Quebec | 12 | $60 | 0.00% | +0+0.5% | AddedConverted for a 1-for-31 split |
| Toth Financial Advisory Corp | 11 | $56 | 0.00% | +11 | New |
| Wells Fargo & Company | 10 | $50 | 0.00% | +0+1.0% | AddedConverted for a 1-for-31 split |
| UBS Group AG | 9 | $45 | 0.00% | −347−97.5% | ReducedConverted for a 1-for-31 split |
| JPMorgan Chase & Co | 5 | $25 | 0.00% | −0−6.6% | ReducedConverted for a 1-for-31 split |
| Citigroup Inc | 4 | $20 | 0.00% | −91−95.8% | ReducedConverted for a 1-for-31 split |
| State Street Corp | 0 | $0 | 0.00% | −4,735−100.0% | Sold outConverted for a 1-for-31 split |
| Northern Trust Corp | 0 | $0 | 0.00% | −3,623−100.0% | Sold outConverted for a 1-for-31 split |
| Millennium Management LLC | 0 | $0 | 0.00% | −2,618−100.0% | Sold outConverted for a 1-for-31 split |
| Sequoia Financial Advisors, LLC | 0 | $0 | 0.00% | −2,032−100.0% | Sold outConverted for a 1-for-31 split |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −1,846−100.0% | Sold outConverted for a 1-for-31 split |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −1,748−100.0% | Sold outConverted for a 1-for-31 split |
| Tocqueville Asset Management L.P. | 0 | $0 | 0.00% | −1,204−100.0% | Sold outConverted for a 1-for-31 split |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −1,079−100.0% | Sold outConverted for a 1-for-31 split |
| TownSquare Capital, LLC | 0 | $0 | 0.00% | −1,046−100.0% | Sold outConverted for a 1-for-31 split |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −952−100.0% | Sold outConverted for a 1-for-31 split |
| HRT Financial LP | 0 | $0 | 0.00% | −939−100.0% | Sold outConverted for a 1-for-31 split |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −823−100.0% | Sold outConverted for a 1-for-31 split |
| Bank of New York Mellon Corp | 0 | $0 | 0.00% | −666−100.0% | Sold outConverted for a 1-for-31 split |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −467−100.0% | Sold outConverted for a 1-for-31 split |
| Prudential Financial Inc | 0 | $0 | 0.00% | −387−100.0% | Sold outConverted for a 1-for-31 split |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −323−100.0% | Sold outConverted for a 1-for-31 split |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −422−100.0% | Sold outConverted for a 1-for-31 split |
| Rhumbline Advisers | 0 | $0 | 0.00% | −75−100.0% | Sold outConverted for a 1-for-31 split |
| Sound Income Strategies, LLC | 0 | $0 | 0.00% | −13−100.0% | Sold outConverted for a 1-for-31 split |
| Perkins Coie Trust Co | 0 | $0 | 0.00% | −6−100.0% | Sold outConverted for a 1-for-31 split |
| Cutler Group LP | 0 | $0 | 0.00% | −32−100.0% | Sold outConverted for a 1-for-31 split |
| DFPG Investments, LLC | – | – | – | – | Not filed |